Acceliant, a global technology provider of innovative clinical solutions, is pleased to announce its participation as a Gold sponsor at the SCDM Annual Conference 2016 from September 11-14, 2016 at San Diego. The Society for Clinical Data Management (SCDM) is a non-profit, international organization of 2,400+ members founded to advance the discipline of clinical data management. SCDM promote quality and excellence in data management and are dedicated to the development, support and advancement of clinical data management professionals.
Commenting on the participation, Vivek Gupta, World Wide VP - Sales, said, "We are delighted to be a Gold sponsor of SCDM - 2016 Annual Conference. This conference provides an ideal opportunity to demonstrate Acceliant eClinical Suite - that offers an efficient way of managing clinical trials and data with an integrated trial builder, EDC platform and e-PRO."
Acceliant has successfully partnered with some of the world's largest and prestigious CROs and Pharmaceutical organizations in their clinical trials. Its comprehensive eClinical solutions enable its clients to manage all phases of the clinical trials in the most efficient way possible.
"We are excited to participate in the event which brings together Clinical Data Management professionals on one platform to exchange knowledge and industry best practices. We invite all the attendees to visit Booth # 108 to learn how Acceliant v7.0 help speed up the clinical trial process and increase the efficiency", said Santhosh Nagaraj, VP Client Relationships, Trianz.
Acceliant is the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant solutions have helped facilitate clinical data management in hundreds of trials worldwide in dozens of therapeutic areas for global giants as well as emerging healthcare innovators. For more information, please visit our website at www.acceliant.com.